We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Desktop MRI System Designed for Easy Use, Easy-to-Site Preclinical and Molecular Imaging

By LabMedica International staff writers
Posted on 30 Sep 2010
Print article
Image: The Icon MRI system (photo courtesy Bruker).
Image: The Icon MRI system (photo courtesy Bruker).
A new easy-to-use 1.0 Tesla desktop magnetic resonance imaging (MRI) scanner combines simplicity with compact dimensions brings preclinical MRI scanning within reach for a wider range of molecular imaging laboratories.

Bruker Corp. (Billerica, MA, USA) announced the introduction of the Icon MRI system, with its innovative cryogen-free permanent magnet from Aspect Magnet Technologies (Netanya, Israel) and high-performance Avance III spectrometer technology with industry-leading preclinical MRI software ParaVision from Bruker, the new Icon system delivers powerful performance and ease of use at an attractive price point.

The Icon is a state-of-the-art and cost-effective MRI instrument for routine preclinical and molecular imaging in biomedical and pharmaceutical applications. Bruker's industry standard MRI software ParaVision guarantees access to a wide range of acquisition and processing tools for in vivo and material science MRI applications. Optional software modules enable the Icon to perform the latest MRI applications, such as relaxometry mapping, fast echo-planar imaging, ultra-short echo time lung imaging, or contrast agent research. As an educational tool, students will find the ParaVision software intuitive, whether it is used to perform research-imaging protocols, or to learn programming of MRI methods.

The new compact shielded permanent magnet with its very small footprint results in an easy to site and install MRI system with almost negligible running costs. Even with a field strength of 1 Tesla, the Icon has zero magnetic fringe field enabling safe location of the system in any facility and for use by any operator. No additional magnetic or radiofrequency (RF) shielding is required for the implementation in the lab. Icon benefits from the Avance III sophisticated digital RF architecture as the technologic basis for the latest MRI applications of today's and tomorrow's preclinical questions.

Dr. Wulf I. Jung, managing director of Bruker BioSpin MRI, GmbH, commented, "High-performance desktop MRI systems have the potential to deliver new research applications to the field of preclinical and molecular imaging. The Icon system is aimed at easy, routine MRI workflows with a compact footprint, low running costs, no magnetic stray fields, and push-button imaging performance, based on the latest Bruker spectrometer and software technology, in order to enable new research groups to enter this fascinating field of preclinical and materials MRI.”

Related Links:

Bruker
Aspect Magnet Technologies




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.